Citius Oncology Inc.

NASDAQ: CTOR · Real-Time Price · USD
1.77
0.14 (8.59%)
At close: Aug 22, 2025, 3:29 PM

Citius Oncology Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q1 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Dec 31, 2022
Net Income
-6.41M -6.41M -4.48M -4.48M -4.36M -4.35M 375.62K 380.81K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
1.81M 1.81M 1.92M 1.92M 1.92M 1.92M 1.97K n/a
Other Working Capital
8.56M 8.56M 3.77M 3.77M 3.82M 3.81M 63.84K 60.79K
Other Non-Cash Items
-633.24K -634.87K -853.06K -957.13K -810.1K -810.54K -592.35K -486.99K
Deferred Income Tax
264.24K 264.24K 144K 144K 144K 144K n/a n/a
Change in Working Capital
4.61M 4.61M 2.69M 2.69M 2.73M 2.73M 63.84K 60.79K
Operating Cash Flow
-363.93K -363.93K -582.12K -687.77K -369.1K -369.1K -150.91K -45.39K
Capital Expenditures
-4.46 -4.46 -4.46 -8.29 -4.84 -4.84 -4.84 -1.01
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-198.53K -198.53K -851.9K -1.49M -64.99M -64.99M -64.34M -63.7M
Sales Maturities Of Investments
175.98K 175.98K 175.98K 175.98K n/a n/a n/a n/a
Other Investing Acitivies
-5K -5K -5K n/a n/a n/a n/a n/a
Investing Cash Flow
-27.55K -27.55K -680.92K -1.32M -64.99M -64.99M -64.34M -63.7M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
358.53K 358.53K 1.23M 1.64M 923.06K 923.06K 47.98K -363.21K
Financial Cash Flow
358.53K 358.53K 1.23M 1.64M 65.31M 65.31M 64.43M 64.02M
Net Cash Flow
n/a n/a 6.22K -337.35K -337.35K -337.35K -343.57K n/a
Free Cash Flow
-363.93K -363.93K -582.12K -687.78K -369.11K -369.11K -150.92K -45.39K